前列腺动脉栓塞术后前列腺的MR影像表现:一项前瞻性2期研究结果
本前瞻性2期研究分析了43例良性前列腺增生患者接受前列腺动脉栓塞术(PAE)前及术后6个月的前列腺MR数据,评估影像和体积变化。术后6个月总前列腺体积(TV)中位下降18.2%,中央腺体体积(CGV)中位下降26.7%,37%基线有膀胱内前列腺突出(IPP)者随访时均见中叶缩小;33%出现梗死征象,79%T2信号降低,51%强化减低,无水肿、前列腺周围脂肪改变或感染/炎症。作者结论认为PAE导致TV和CGV显著缩小,并减少IPP程度,同时可见非特异性梗死、T2信号降低和强化减低。
要点
- PAE术后6个月93%(30/43)患者总前列腺体积下降、100%(43/43)中央腺体体积下降。
- 37%(16/43)基线有膀胱内前列腺突出(IPP)者,随访时全部显示中叶缩小。
- 术后6个月33%(14/43)出现梗死征象、79%(34/43)T2信号降低、51%(22/43)强化减低。
核心结论
- PAE导致总前列腺体积(TV)和中央腺体体积(CGV)统计学显著缩小,膀胱内前列腺突出(IPP)程度亦减轻;同时可见梗死、T2信号降低和强化减低等非特异性表现。
研究设计与样本
- 前瞻性2期研究,经IRB批准,分析2015年至2017年PAE患者基线和术后6个月前瞻性采集的MR数据,共43例(n=43)符合纳入标准;使用DynaCAD®计算总前列腺体积(TV)和中央腺体体积(CGV),SPSS分析,p<0.05认为有统计学意义。
关键影像表现/征象
- 术后6个月33%(14/43)出现梗死影像学特征,79%(34/43)T2信号强度降低,51%(22/43)强化减低。
- 无患者出现水肿、前列腺周围脂肪改变或感染/炎症。
- 37%(16/43)基线有膀胱内前列腺突出(IPP),随访时100%显示中叶缩小。
诊断标准与关键数值
- 基线总前列腺体积(TV)中位86 cc(范围29.4-232),中央腺体体积(CGV)中位54.4 cc(范围12.9-165.5)。
- 术后6个月TV中位下降18.2%(CI 13.3-27.2)(p=0.0001),CGV中位下降26.7%(CI 20.4-35.9)(p=0.0001)。
- 93%(30/43)患者TV下降,100%(43/43)患者CGV下降。
临床应用与阅片要点
- 阅片时注意评估PAE术后前列腺T2信号降低、强化减低和梗死征象,这些为非特异性表现。
- 报告时应测量并比较总前列腺体积(TV)和中央腺体体积(CGV),并评估膀胱内前列腺突出(IPP)的变化。
- 注意排除水肿、前列腺周围脂肪改变或感染/炎症等术后并发症表现。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To assess changes in imaging and volume characteristics of the prostate gland by magnetic resonance (MR) following prostatic artery embolization (PAE) for benign prostate hyperplasia.
METHODS: With IRB approval, we analyzed prospectively acquired MR data of PAE patients at baseline and 6-month following treatment from 2015 to 2017. We reviewed prostate MRs looking for sequelae of embolization [changes in signal intensity and/or enhancement, infection/inflammation, infarction, edema, and change in intravesical prostatic protrusion (IPP)]. We calculated the total volume (TV) and central gland volumes (CGV) using DynaCAD® and measured change in volumes. Analyses were performed using SPSS with p < 0.05 considered significant.
RESULTS: Forty-three patients (n = 43) met our inclusion criteria. 93% (30/43) and 100% (43/43) showed a decrease in TV and CGV at 6-months respectively. At baseline, median TV was 86 cc (range 29.4-232) and median CGV was 54.4 cc (range 12.9-165.5). Median decrease in TV was 18.2% (CI 13.3-27.2) (p = 0.0001) and median decrease in CGV was 26.7% (CI 20.4-35.9) (p = 0.0001). Thirty-seven percent (16/43) of patients had IPP at baseline; 100% showed a decrease in size of median lobe at follow-up. At 6-month follow-up, 33% (14/43) showed imaging features of infarction, 79% (34/43) had decrease in T2-signal intensity, and 51% (22/43) showed a decrease in enhancement. None had edema, peri-prostatic fat changes or infection/inflammation.
CONCLUSION: PAE causes a statistically significant reduction in the TV and CGV. There is also a reduction of the degree of IPP. Non-specific findings of infarction, decrease in T2-signal, and enhancement were also seen.
引用
- Ali R, Gabr A, Mouli SK, et al. MR imaging findings of the prostate gland following prostate artery embolization: results from a prospective phase 2 study. Abdom Radiol (NY). 2019. PMID: 30196364. doi:10.1007/s00261-018-1757-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。